Cargando…
Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study
Data on the association between aspirin and statin use and Pancreatic Ductal AdenoCarcinoma (PDAC) risk are conflicting. These drugs are often co-prescribed, but no studies evaluated the potential combined or confounding effect of the two at the same time. We aimed to investigate the association bet...
Autores principales: | Archibugi, Livia, Piciucchi, Matteo, Stigliano, Serena, Valente, Roberto, Zerboni, Giulia, Barucca, Viola, Milella, Michele, Maisonneuve, Patrick, Delle Fave, Gianfranco, Capurso, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638859/ https://www.ncbi.nlm.nih.gov/pubmed/29026148 http://dx.doi.org/10.1038/s41598-017-13430-z |
Ejemplares similares
-
The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients
por: Piciucchi, Matteo, et al.
Publicado: (2017) -
Exocrine Pancreatic Insufficiency in Diabetic Patients: Prevalence, Mechanisms, and Treatment
por: Piciucchi, Matteo, et al.
Publicado: (2015) -
Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition
por: Passacantilli, Ilaria, et al.
Publicado: (2014) -
Endoscopy-guided ablation of pancreatic lesions: Technical possibilities and clinical outlook
por: Signoretti, Marianna, et al.
Publicado: (2017) -
Cost–effectiveness of pancreatic cancer screening: Time for a more tailored approach
por: Archibugi, Livia, et al.
Publicado: (2023)